Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,897,922
+$1,614,764 QoQ
Shares Held
5,751
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,481
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. LLY ranks #4 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
|
4,542 | $711,822 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,897,922 | 5,751 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,283,158 | 5,744 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,469,574 | 6,020 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,547,480 | 5,960 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,396,549 | 5,640 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,511,120 | 5,462 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $5,320,624 | 6,892 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,953,516 | 6,720 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,111,315 | 6,750 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,159,430 | 6,632 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,846,106 | 6,598 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,948,843 | 5,490 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,985,392 | 8,498 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,956,502 | 8,609 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,149,516 | 8,609 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,781,456 | 8,602 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,912,233 | 8,982 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,550,411 | 8,906 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,460,015 | 8,906 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,020,532 | 8,745 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,006,922 | 8,744 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,633,554 | 8,744 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,484,610 | 8,793 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,301,391 | 8,792 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,460,709 | 8,897 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,598,193 | 11,521 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||